Boston Scientific Corporation (BSX) vs Edwards Lifesciences Corporation (EW)
- Boston Scientific Corporation BSX 44.39 +0.57%
- Edwards Lifesciences Corporation EW 86.60 −1.70%
Boston Scientific Corporation and Edwards Lifesciences Corporation are both Medical Devices companies. Boston Scientific Corporation is the larger, with a market value of $64.0B against $50.8B — 1.3× the size. Boston Scientific Corporation trades at the lower P/E: 17.9× against 49.8×. Edwards Lifesciences Corporation grew revenue faster over the last twelve months: 14.6% against 13.5%. Boston Scientific Corporation has the higher net margin (17.5% vs 15.4%) and the lower return on invested capital (6.96% vs 12.8%). Across the 22 metrics below, Boston Scientific Corporation leads on 13 and Edwards Lifesciences Corporation on 9.
Valuation
Profitability
| Metric | BSX | EW | Medical Devices median |
|---|---|---|---|
| Gross margin | 69.92% | 77.84% | 56.01% |
| Operating margin | 19.76% | 22.25% | (15.03%) |
| Net margin | 17.50% | 15.43% | (20.40%) |
| Free cash flow margin | 17.27% | 22.01% | (7.24%) |
| Return on equity | 15.37% | 9.42% | (15.32%) |
| Return on assets | 8.47% | 7.35% | (19.72%) |
| Return on invested capital | 6.96% | 12.81% | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack